Products for Research Use Only
RegisterLogin

DOTA-LM3 TFA

CAT: 0013-GTR19062150-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19062150-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOTA-LM3 TFA is a somatostatin receptor antagonist peptide used in nuclear medicine research. Its 68Ga-labeled version is a promising PET imaging agent for SSTR-positive tumors, while the 177Lu-labeled analogue is studied for targeted radionuclide therapy, particularly in DOTATOC-negative metastases.
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1664.18
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19061998-01DOTA-LM3
GTR19061920-01NODAGA-LM3 TFA
GTR19247793-01DOTA-ADIBO TFA
GTR19113322-01DOTA-Octreotide TFA
GTR19239226-01DOTA-​NHS-ester TFA
GTR19239615-01C (avb6) -DOTA TFA
GTR19238408-01DOTA.SA.FAPi TFA
GTR19144673-01DOTA-Pep-1L TFA
GTR19144846-01DOTA-Bombesin (1-14) TFA
GTR19247776-01DOTA-NHS-ester hexafluorophosphate TFA

Alternative Products

CatalogName
HY-P5126-01DOTA-LM3
A23503-10DOTA-LM3 10mg
HY-P5126A-01DOTA-LM3 (TFA)
T78110-01DOTA-LM3 TFA
A23503-5DOTA-LM3 5mg
A23503-1DOTA-LM3 1mg
MBS5821896NODAGA-LM3
MBS5821897NODAGA-LM3 TFA
HY-P5362ANODAGA-LM3 (TFA)
TRC-D535500-250MGDOTA

Popular Products